Should you buy, hold, or sell CBA, CSL, and Pilbara Minerals shares?

Let's see what analysts are saying about these big names.

| More on:
Middle age caucasian man smiling confident drinking coffee at home.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There are 200 shares for investors to choose from on the ASX 200 index.

To narrow things down for investors, let's take a look at three very popular shares that Fairmont Equities has given its verdict on, courtesy of The Bull.

Here's what it is saying about these giants:

Commonwealth Bank of Australia (ASX: CBA)

Fairmont Equities was bullish on Australia's largest bank last year and benefited from its record-breaking rally.

However, with its shares looking expensive and its share price chart showing signs of weakness, it feels that now is the time to sell. It explains:

We turned bullish on CBA in early 2024 as it broke above a major resistance level and started to rally. We remained bullish until recently when the share price chart finally showed signs of weakness. This also coincides with long held investor concerns around CBA's valuation. While we didn't sell CBA on valuation grounds and rode it higher in the past 18 months, a topping signal on the chart is a sign to finally exit this position, in our view.

CSL Ltd (ASX: CSL)

Another ASX 200 share that Fairmont Equities has been looking at is biotherapeutics giant CSL.

Its analysts note that the company's shares have been recovering in recent months. And while they have stopped short of calling it a buy, they think it would be one to hold tightly to for the future. They explain:

This global biotechnology giant provides medicines to patients in more than 100 countries. The company makes vaccines to prevent influenza. Its medicines treat haemophilia and immune deficiencies, and it offers therapies in iron deficiency and nephrology. The share price is starting to recover from its lows in response to mixed first half results in fiscal year 2025 and uncertainty surrounding US tariffs. The shares have risen from $234.34 on June 27 to trade at $271.56 on July 31. We view CSL as a solid hold for capital growth and income.

Pilbara Minerals Ltd (ASX: PLS)

Finally, Fairmont Equities has been looking at lithium giant Pilbara Minerals.

Its analysts are optimistic that a recovery could be on the cards for its shares. However, they are not confident enough to call it a buy just yet and instead rate Pilbara Minerals as a hold. They said:

Most lithium miners have rallied well in the past few weeks and there are signs the sector is at or near the bottom. Like most lithium miners, PLS had been trending lower for the past two years, but it recently reached a new peak on the share price chart by breaking above the May high on good volume. It's early days, but this could be the first step in PLS breaking the downtrend and embarking on a likely recovery.

Motley Fool contributor James Mickleboro has positions in CSL. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, holding a mobile phone in his hand while thinking about something.
Broker Notes

3 ASX All Ords shares tipped to rise 30% to 80% in 2026

Looking for New Year's investment inspiration?

Read more »

Man in yellow hard hat looks through binoculars as man in white hard hat stands behind him and points.
Broker Notes

4 ASX shares to buy in the market's best-performing sector of 2025

Do these companies deserve a spot in your portfolio?

Read more »

A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.
Broker Notes

Buy, hold, sell: AGL, Coles, and PLS shares

Are analysts bullish or bearish on these shares?

Read more »

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Broker Notes

Experts rate these 2 ASX shares as buys this month!

Leading analysts say these stocks are a buy.

Read more »

Man reading an e-book with his feet up and piles of books next to him.
Broker Notes

What's Bell Potter's view on SGH shares after the BlueScope Steel acquisition proposal?

What should investors expect after Monday's announcement?

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: How does Morgans rate these ASX shares?

Morgans has been looking at a couple of popular shares.

Read more »

A man pulls a shocked expression with mouth wide open as he holds up his laptop.
Broker Notes

Why this beaten down ASX 200 stock could rise 50%

This stock could be dirt cheap according to analysts at Bell Potter.

Read more »